世界中医药2024,Vol.19Issue(5) :753-757.DOI:10.3969/j.issn.1673-7202.2024.05.026

活血化瘀法治疗子宫肌瘤的理论及作用机制

Theoretical Basis and Modern Mechanism of Activating Blood and Resolving Stasis in the Treatment of Uterine Fibroids

史莎莎 余成浩
世界中医药2024,Vol.19Issue(5) :753-757.DOI:10.3969/j.issn.1673-7202.2024.05.026

活血化瘀法治疗子宫肌瘤的理论及作用机制

Theoretical Basis and Modern Mechanism of Activating Blood and Resolving Stasis in the Treatment of Uterine Fibroids

史莎莎 1余成浩2
扫码查看

作者信息

  • 1. 陕西中医药大学,咸阳,712046
  • 2. 西南特色中药资源国家重点实验室,成都中医药大学,成都,610075
  • 折叠

摘要

现代高发的子宫肌瘤疾病属于中医学"癥瘕"范畴,历代医家多认为"血瘀"是癥瘕的主要病机,目前,活血化瘀法已成为临床治疗子宫肌瘤的主要治法.本文从中医学对子宫肌瘤病因、病机的认识入手,结合现代医学对活血化瘀方的研究,阐述了活血化瘀法治疗子宫肌瘤的理论依据及主要机制.

Abstract

Uterine fibroids with high incidence in modern times is a disease of abdominal mass in TCM,and doctors of past dynas-ties mostly believe that blood stasis is the main pathogenesis of abdominal mass.Therefore,activating blood and resolving stasis has become the main method in the clinical treatment of uterine fibroids.According to the TCM understanding about the etiology and pathogenesis of uterine fibroids and the modern studies of prescriptions for activating blood and resolving stasis,this article elabo-rates on the theoretical basis and main mechanism of treating uterine fibroids by activating blood and resolving stasis.

关键词

活血化瘀法/子宫肌瘤/病因/病机/血瘀/癥瘕

Key words

Method of activating blood and resolving stasis/Uterine fibroids/Etiology/Pathogenesis/Blood stasis/Abdominal mass

引用本文复制引用

基金项目

国家自然科学基金(81673878)

四川省科技计划(2020JDTD0022)

出版年

2024
世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
参考文献量41
段落导航相关论文